Palmitoyl Peptides (Matrixyl)

The most common 'anti-wrinkle' peptides in skincare serums (e.g. palmitoyl pentapeptide-4, sold as Matrixyl). Small clinical studies — many manufacturer-funded — report modest improvements in fine lines and firmness over 8–12 weeks. A cosmetic ingredient, not a drug; results depend heavily on formulation and whether the peptide actually penetrates the skin.

Anthivera’s calibrated five-tier scale — what the strongest evidence on Palmitoyl Peptides (Matrixyl) actually supports today.

1. Preclinical
2. Limited clinicalPalmitoyl
3. Multiple human studies
4. Phase 3
5. FDA-approved

Limited clinical: Small open-label or case-report data in humans.

1. 01What evidence is there for Palmitoyl Peptides (Matrixyl) in women specifically — and does that include perimenopausal or postmenopausal cohorts?
2. 02What is the current FDA regulatory status, and which compounding pharmacy will my prescription go through?
3. 03What baseline labs do you require before starting, and how often do you monitor?
4. 04What are the realistic timelines and what does “not working for you” look like in practice?

• Do Peptide Serums Actually Work? Your Skincare Peptides, Graded

  Peptide serums are one of the biggest skincare categories sold to women — but the 2026 evidence is more complicated than the marketing. The penetration problem, why oral may beat topical, and an honest grade of the peptides in your serum.